INSIGHTS ON CLINICAL TRIAL DESIGN
-
Why Site Engagement Belongs At Investigators' Meetings
Investigators’ meetings are a great opportunity to give sites direct access to the teams supporting patient travel and reimbursement, clarify available services early, and surface practical needs before they become study barriers.
-
The Impact Of High Inflation And The Great Resignation On Clinical Site Budgeting
The twin pressures of inflation and attrition prolong negotiations between sponsors and clinical sites, stalling drug development. Sponsors need up-to-date, reliable benchmark data to negotiate fair market value budgets.
-
What Clinical Trial Management Solutions Don't Cover: The Ocular Endpoint Execution Gap
Discover how specialized endpoint execution closes critical gaps in ophthalmic trials, improving assessment consistency, protocol adherence, data quality, and participant retention.
-
Mastering Scope 3 Emissions In Clinical Trials
Explore innovative strategies for reducing Scope 3 emissions in clinical trials. Discover sustainable solutions that uphold quality and outcomes, crucial for achieving net-zero goals in healthcare research.
-
Lack Of IRT/RTSM System Reusability Surprises Every Clinical Trial Sponsor2/26/2026
Stop re-learning your IRT system with every new trial. Uncover why "standard" features often hide custom complexities that slow down UAT and clinical operations.
-
FDA Guidance On Payment And Reimbursement To Research Subjects12/5/2025
Learn how ethical, fair, and timely payment and reimbursement strategies can support participants, enhance trial accessibility, and uphold regulatory and IRB standards.
-
Patient Support Solutions For Clinical Trials5/14/2025
Learn how Greenphire leverages its more than 17 years of experience to deliver the most flexible and comprehensive patient-focused solutions and services.
-
All You Need To Know About 505(b)(2), But Were Afraid To Ask7/18/2025
Join us to explore the 505(b)(2) pathway. Learn how to bring improved drugs to market faster, reduce costs, and add value with this streamlined regulatory approach.
-
Solutions To The Challenges Of Oncology Trials5/6/2025
This significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Patient retention has benefits beyond what’s reflected in a data set. Explore some of the ways clinical trial participation can have a transformative impact on patients and their families.
-
See how Citeline Connect is expanding sponsors’ reach to the right patients through a marketplace of 100+ recruitment vendors and a network of 1.7 million-plus healthcare professionals through a single platform.
-
Bridge the gap between raw data and clinical enrollment. Use AI-driven insights and natural language summaries to identify the right patients faster and with greater transparency.
-
Explore this suite of multichannel, patient-centered solutions that are powering rapid clinical trial education, engagement, and enrollment.
-
Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.